Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

895241

registered interest
date	01/05/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Hospitals: Food
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, how much funding his Department allocates to hospitals for providing food for patients with special dietary requirements.
tabling member constituency	Leicester South
tabling member printed	Jonathan Ashworth
uin	140105
answer	answer is ministerial correction date of answer 08/05/2018 answer text <p>Providers are not funded directly by the Department. The majority of the Department’s funding is allocated to NHS England, primarily for the commissioning of healthcare services from a range of primary and secondary care providers. National Health Service providers (NHS trusts and foundation trusts) fund their spending via income received from NHS commissioners in return for the provision of healthcare services to their local population. It is for commissioners to ensure that providers’ services meet the standards, including for providing food for patients with special dietary requirements, set out by the Care Quality Commission.</p> answering member constituency North East Cambridgeshire answering member printed Stephen Barclay question first answered 08/05/2018 10:42:53 answering member 4095 label Biography information for Steve Barclay
tabling member	4244 label Biography information for Jonathan Ashworth

872581

registered interest
date	27/03/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	European Reference Networks
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what discussions he has had with representatives of the devolved administrations on the work of the European Reference Networks after the UK leaves the EU.
tabling member constituency	Belfast North
tabling member printed	Nigel Dodds
uin	134395
answer	answer is ministerial correction date of answer 04/04/2018 answer text <p>The Government's policy paper, ‘Collaboration on Science and Innovation: A Future Partnership Paper’ stresses the importance of continued collaboration with European partners to ensure that the United Kingdom remains one of the best places in the world for science and innovation. European Reference Networks (ERNs) for rare diseases patients were cited in the paper as an example of collaboration that the UK and European Union need to discuss in the negotiations.</p><p>ERNs are a cornerstone of the UK Strategy for Rare Diseases. Implementation of the Strategy is overseen by the UK Policy Board which has representation from all of the four UK nations.</p><p>The Government has been clear from the start that the devolved administrations should be fully engaged in our preparations to leave the EU, including through the Joint Ministerial Committee on EU Negotiations.</p><p>We are committed to positive and productive engagement with the devolved administrations going forward as we seek a deal that works for the entire UK.</p> answering member constituency Gosport answering member printed Caroline Dinenage question first answered 04/04/2018 14:13:43 answering member 4008 label Biography information for Dame Caroline Dinenage
tabling member	1388 label Biography information for Lord Dodds of Duncairn

872594

registered interest
date	27/03/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Cancer Drugs Fund
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what the timetable is for the publication of the review of the Cancer Drugs Fund.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	134408
answer	answer is ministerial correction date of answer 03/04/2018 answer text <p>A review of the operation of the Cancer Drugs Fund is currently underway. A summary report from this review is anticipated during 2018-19.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 03/04/2018 13:21:04 answering member 4067 label Biography information for Steve Brine
tabling member	4131 label Biography information for Jim Shannon

872595

registered interest
date	27/03/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Cancer: Immunotherapy
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what progress has been made on recommendation 32 of the NHS Cancer Strategy, Achieving World Class Outcomes, on the adoption of immunotherapy treatments.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	134409
answer	answer is ministerial correction date of answer 03/04/2018 answer text <p>The development of immunotherapies for the treatment of cancer is an emergent area of clinical practice. The National Institute for Health and Care Excellence has recommended a number of immunotherapies for routine use on the National Health Service, and these are commissioned by NHS England.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 134411 question first answered 03/04/2018 13:20:12 answering member 4067 label Biography information for Steve Brine
tabling member	4131 label Biography information for Jim Shannon

872596

registered interest
date	27/03/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Glaucoma
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what new procedures and operations for treating glaucoma are planned to become available on the NHS; and if he will make a statement.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	134410
answer	answer is ministerial correction date of answer 03/04/2018 answer text <p>The National Institute for Health and Care Excellence (NICE) has recently published interventional procedures guidance on a number of new procedures and is currently developing guidance on another, all for use in the treatment of glaucoma.</p><p>NICE interventional procedures guidance makes recommendations for the National Health Service on whether new operational procedures are sufficiently safe and efficacious for routine use in clinical practice, but does not provide guidance on whether such procedures represent a clinically and cost effective use of NHS resources.</p><p>It is for commissioners locally to decide based on the available evidence whether to fund a procedure recommended in NICE interventional procedures guidance or any other procedure.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 03/04/2018 13:18:29 answering member 4067 label Biography information for Steve Brine
tabling member	4131 label Biography information for Jim Shannon

872597

registered interest
date	27/03/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Cancer: Medical Treatments
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what progress has been made on implementing recommendation 32 of the NHS Cancer Strategy on the adaptation of immunotheropy treatments.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	134411
answer	answer is ministerial correction date of answer 03/04/2018 answer text <p>The development of immunotherapies for the treatment of cancer is an emergent area of clinical practice. The National Institute for Health and Care Excellence has recommended a number of immunotherapies for routine use on the National Health Service, and these are commissioned by NHS England.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 134409 question first answered 03/04/2018 13:20:12 answering member 4067 label Biography information for Steve Brine
tabling member	4131 label Biography information for Jim Shannon

872615

registered interest
date	27/03/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	NHS: Hygiene
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the potential merits of automated electronic monitoring of hand gel usage as a means of collecting more accurate data on hand hygiene compliance.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	134429
answer	answer is ministerial correction date of answer 29/03/2018 answer text <p>NHS Improvement is leading work to drive down healthcare associated infections and as part of this have carried out an early assessment of electronic monitoring of hand gel usage. The technology used in some trusts is currently reliant on local data infrastructure and many existing systems would not be able to support it.</p><p> </p><p>It is important to note that automated monitoring of hand gel and soap usage does not address the correct techniques of hand hygiene by healthcare staff. This is important in reducing the spread of infections. NHS Improvement’s work programme for 2018/19 includes a workstream on hand hygiene compliance and monitoring.</p><p> </p><p>We are working with our partners across the health and social care system, including the Care Quality Commission, to ensure that consideration of best practice in hand hygiene policies remains a focus of inspections in acute trusts.</p> answering member constituency Gosport answering member printed Caroline Dinenage question first answered 29/03/2018 15:42:52 answering member 4008 label Biography information for Dame Caroline Dinenage
tabling member	4131 label Biography information for Jim Shannon

872621

registered interest
date	27/03/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Alzheimer's Disease
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps he is taking to ensure that sufficient funding is available to provide drugs for Alzheimer's disease to patients.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	134435
answer	answer is ministerial correction date of answer 04/04/2018 answer text <p>The Government remains strongly committed to supporting research into dementia and the United Kingdom research community is playing a significant role in the global effort to find a cure or a major disease-modifying treatment by 2025.</p><p>The Government has doubled research spending on dementia, with a commitment to maintain this level of spending of at least £60 million a year to 2020, with an ambition for overall spending on research from all sectors to double by 2025. Much of this investment is in research to better understand the nature of dementia, to inform development of future treatments and ways to prevent the onset of the condition.</p><p>We will need to consider the potential impacts that new and emerging treatments for Alzheimer’s disease may have on the health system. We will engage with initiatives such as Alzheimer’s Research UK’s proposed Taskforce which seek to identify innovative and cooperative solutions for making available future medicines and diagnostic approaches for people living with dementia.</p> answering member constituency Gosport answering member printed Caroline Dinenage question first answered 04/04/2018 14:10:46 answering member 4008 label Biography information for Dame Caroline Dinenage
tabling member	4131 label Biography information for Jim Shannon

872651

registered interest
date	27/03/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Health Services: Reciprocal Arrangements
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, how much money the UK (a) received from EU Member States for the treatment of EU nationals in the UK on the NHS and (b) paid to EU Member States for the treatment of UK nationals in 2017.
tabling member constituency	Wokingham
tabling member printed	John Redwood
uin	134465
answer	answer is ministerial correction date of answer 03/04/2018 answer text <p>The Department on behalf of the United Kingdom Government reimburses other European Economic Area (EEA) countries and Switzerland for the cost of providing treatment to people we are responsible for under European Union law, irrespective of nationality. In the same way, other EEA countries and Switzerland reimburse the UK for the cost of the National Health Service providing treatment to people they are responsible for under EU law, including UK nationals insured in another EEA country or Switzerland.</p><p>Member State claims against the UK are in local currency so totals are significantly affected by the exchange rate at the time of payment and can mean a difference of millions of pounds. Member States can submit claims up to 18 months in arrears so claims for any 12 month period do not necessarily reflect treatment provided in that period.</p><p>Requested figures, for financial year 2016/17, are provided rounded to the nearest pound.</p><table><tbody><tr><td><p>EEA Medical Costs</p></td></tr><tr><td><p>UK Claims against Member States</p></td></tr><tr><td><p>Resource Outturn Totals:</p></td></tr><tr><td><p>2016-17 Activity</p></td></tr><tr><td><p> </p></td><td><p>Total</p></td></tr><tr><td><p>Austria</p></td><td><p>£568,972</p></td></tr><tr><td><p>Belgium</p></td><td><p>£3,312,035</p></td></tr><tr><td><p>Bulgaria</p></td><td><p>£2,280,152</p></td></tr><tr><td><p>Cyprus</p></td><td><p>£468,363</p></td></tr><tr><td><p>Czech Republic</p></td><td><p>£516,385</p></td></tr><tr><td><p>Denmark (Waiver)</p></td><td><p>£0</p></td></tr><tr><td><p>Estonia (Waiver)</p></td><td><p>£142,688</p></td></tr><tr><td><p>Finland (Waiver)</p></td><td><p>£169,887</p></td></tr><tr><td><p>France</p></td><td><p>£5,253,748</p></td></tr><tr><td><p>Germany</p></td><td><p>£3,166,282</p></td></tr><tr><td><p>Greece</p></td><td><p>£853,919</p></td></tr><tr><td><p>Hungary (Waiver)</p></td><td><p>£24,466</p></td></tr><tr><td><p>Iceland</p></td><td><p>£38,223</p></td></tr><tr><td><p>Ireland</p></td><td><p>£18,477,152</p></td></tr><tr><td><p>Italy</p></td><td><p>£2,340,368</p></td></tr><tr><td><p>Latvia</p></td><td><p>£1,352,936</p></td></tr><tr><td><p>Liechtenstein</p></td><td><p>£0</p></td></tr><tr><td><p>Lithuania</p></td><td><p>£2,152,090</p></td></tr><tr><td><p>Luxembourg</p></td><td><p>£163,818</p></td></tr><tr><td><p>Malta (Waiver)</p></td><td><p>£0</p></td></tr><tr><td><p>Netherlands</p></td><td><p>£4,426,768</p></td></tr><tr><td><p>Norway (Waiver)</p></td><td><p>£731</p></td></tr><tr><td><p>Poland</p></td><td><p>£9,468,363</p></td></tr><tr><td><p>Portugal</p></td><td><p>£1,964,165</p></td></tr><tr><td><p>Romania</p></td><td><p>£1,705,136</p></td></tr><tr><td><p>Slovakia</p></td><td><p>£967,572</p></td></tr><tr><td><p>Slovenia</p></td><td><p>£225,503</p></td></tr><tr><td><p>Spain</p></td><td><p>£4,237,456</p></td></tr><tr><td><p>Sweden</p></td><td><p>£1,616,401</p></td></tr><tr><td><p>Switzerland</p></td><td><p>£595,370</p></td></tr><tr><td><p>Total</p></td><td><p>£66,488,946</p></td></tr></tbody></table><p> </p><p> </p><table><tbody><tr><td><p>EEA Medical Costs</p></td></tr><tr><td><p>Member State Claims against the UK</p></td></tr><tr><td><p>Resource Outturn Totals:</p></td></tr><tr><td><p>2016-17 Activity</p></td></tr><tr><td><p> </p></td><td><p>Total</p></td></tr><tr><td><p>Austria</p></td><td><p>£6,269,483</p></td></tr><tr><td><p>Belgium</p></td><td><p>£5,704,185</p></td></tr><tr><td><p>Bulgaria</p></td><td><p>£306,178</p></td></tr><tr><td><p>Croatia</p></td><td><p>£191,219</p></td></tr><tr><td><p>Cyprus</p></td><td><p>£14,838,498</p></td></tr><tr><td><p>Czech Republic</p></td><td><p>£719,998</p></td></tr><tr><td><p>Denmark (Waiver)</p></td><td><p>£0</p></td></tr><tr><td><p>Estonia (Waiver)</p></td><td><p>£0</p></td></tr><tr><td><p>Finland (Waiver)</p></td><td><p>£15,588</p></td></tr><tr><td><p>France</p></td><td><p>£154,683,554</p></td></tr><tr><td><p>Germany</p></td><td><p>£17,988,547</p></td></tr><tr><td><p>Greece</p></td><td><p>£1,696,191</p></td></tr><tr><td><p>Hungary (Waiver)</p></td><td><p>£5,058</p></td></tr><tr><td><p>Iceland</p></td><td><p>£297,460</p></td></tr><tr><td><p>Ireland</p></td><td><p>£194,726,929</p></td></tr><tr><td><p>Italy</p></td><td><p>£6,554,335</p></td></tr><tr><td><p>Latvia</p></td><td><p>£15,319</p></td></tr><tr><td><p>Liechtenstein</p></td><td><p>£1,944</p></td></tr><tr><td><p>Lithuania</p></td><td><p>£126,242</p></td></tr><tr><td><p>Luxembourg</p></td><td><p>£531,360</p></td></tr><tr><td><p>Malta (Waiver)</p></td><td><p>£0</p></td></tr><tr><td><p>Netherlands</p></td><td><p>£5,285,569</p></td></tr><tr><td><p>Norway (Waiver)</p></td><td><p>£2,752</p></td></tr><tr><td><p>Poland</p></td><td><p>£4,336,048</p></td></tr><tr><td><p>Portugal</p></td><td><p>£5,949,767</p></td></tr><tr><td><p>Romania</p></td><td><p>£13,675</p></td></tr><tr><td><p>Slovakia</p></td><td><p>£551,667</p></td></tr><tr><td><p>Slovenia</p></td><td><p>£257,592</p></td></tr><tr><td><p>Spain</p></td><td><p>£201,343,160</p></td></tr><tr><td><p>Sweden</p></td><td><p>£2,223,612</p></td></tr><tr><td><p>Switzerland</p></td><td><p>£5,522,262</p></td></tr><tr><td><p>Total</p></td><td><p>£630,158,194</p></td></tr></tbody></table><p> </p><p>Source: Resource Accounting and Budgeting exercise. Totals are based on estimates of the costs of EEA healthcare claims made annually for the purposes of provisions made in the Department’s accounts in accordance with Treasury resource accounting rules. Country totals are rounded to the nearest pound.</p><p>Notes: Waiver is an agreed intentional relinquishment of healthcare costs between Member States</p><p>1. Denmark - Full waiver</p><p>2. Estonia and Norway - Waiver, except former Article 22.1c (patient referral) and Article 55.1c (industrial injury) claims.</p><p>3. Finland, Hungary and Malta - Waiver, except former Article 22.1c (patient referral) claims.</p><p> </p><p>Figures for 2017-18 should be published over the summer.</p><p> </p><p> </p> answering member constituency North East Cambridgeshire answering member printed Stephen Barclay question first answered 03/04/2018 09:47:55 answering member 4095 label Biography information for Steve Barclay
tabling member	14 label Biography information for Sir John Redwood

872652

registered interest
date	27/03/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Health Services: Foreign Nationals
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, how much money the NHS collected in charges for the non-emergency treatment of visitors to the UK in 2017.
tabling member constituency	Wokingham
tabling member printed	John Redwood
uin	134466
answer	answer is ministerial correction date of answer 03/04/2018 answer text <p>The amounts identified and recovered for the 2017/18 financial year will be made available once National Health Service trusts and NHS foundation trusts have published their Annual Accounts.</p><p>However, in 2016/17, identified income from charging overseas visitors for NHS services was £81.4 million and cash recovered was £30.4 million.</p> answering member constituency North East Cambridgeshire answering member printed Stephen Barclay question first answered 03/04/2018 10:03:45 answering member 4095 label Biography information for Steve Barclay
tabling member	14 label Biography information for Sir John Redwood